Lifestance Health Group Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Lifestance Health Group Inc in the second quarter 2026?
Lifestance Health Group Inc achieved a return on average equity (ROE) of 3.39 % in its second quarter 2026 a new company high.

ROE has advanced compared to 1.56% in the first quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 55 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 1443 to 2221.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	0.22 %	1.39 %	5.17 %	3.87 %	-
Y / Y Net Income Change	-	1908.89 %	-	51.9 %	-
Net Income (TTM) in Millions	51	23	10	-9	-9
Return On Equity (TTM)	3.39 %	1.56 %	0.65 %	-0.62 %	-0.65 %
LFST's Total Ranking	# 2221	# 1443	# 1696	# 2112	# 2075
Equity (TTM) in Millions	1,477	1,477	1,521	1,493	1,474
Seq. Equity Change	-0.02 %	-2.87 %	1.89 %	1.28 %	1.15 %
Seq. Net Income Change	65.78 %	22.07 %	983.38 %	-	-

Back to LFST Management Effectiveness >> LFST's 5 Years Annual ROE >> Compare LFST ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 56
Sector	# 173
Overall	# 2221

Return On Equity Statistics
High	Average	Low
3.39 %	-7.65 %	-23.33 %
(Jun 30 2026)		(Jun 30 2022)

LFST Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	1,521	1,446	1,429	1,519	1,545
Y / Y Equity Change	5.17 %	1.21 %	-5.91 %	-1.7 %	-
Net Income in Millions	10	-57	-186	-216	-307
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	0.64 %	-3.97 %	-13.04 %	-14.19 %	-19.88 %

Back to LFST Management Effectiveness >> LFST's 5 Years Annual ROE >> Compare LFST ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 0.64 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
LFST's' Return on Equity at Yahoo Finance
LFST's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for LFST's Competitors
Subscribers only: Roe for Lifestance Health Group Inc 's Suppliers
Subscribers only: Return On Equity for LFST's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Teva Pharmaceutical Industries Limited	9.11 %
Merit Medical Systems Inc	9.07 %
Bio techne Corp	9.01 %
Utah Medical Products Inc	8.74 %
Vaso Corporation	8.65 %
Veracyte Inc	8.64 %
Corcept Therapeutics Inc	8.27 %
Integer Holdings Corporation	7.43 %
Pacific Health Care Organization Inc	7.42 %
Vericel Corporation	6.91 %
The Cooper Companies Inc	6.90 %
Siga Technologies Inc	6.74 %
Merck and Co Inc	6.59 %
Zimmer Biomet Holdings Inc	6.36 %
National Vision Holdings Inc	5.71 %
Conmed Corporation	5.51 %
Pfizer Inc	4.91 %
Privia Health Group Inc	4.23 %
Becton Dickinson And Company	3.79 %
Alkermes Plc	3.72 %
Lifemd Inc	3.47 %
Lifestance Health Group Inc	3.39 %
Revvity Inc	3.27 %
Bio rad Laboratories Inc	3.15 %
Envista Holdings Corporation	3.08 %
Immucell Corporation	2.68 %
Surgery Partners Inc	2.63 %
Mimedx Group Inc	2.61 %
Cormedix Inc	2.18 %
Atricure Inc	2.14 %

Date modified: 2026-09-12T06:25:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.